To improve productivity, reduce cost of goods and increase manufacturing flexibility, the Biotech Development Center shifted biologics production from batch to continuous processing, reimagining both process development and GMP clinical manufacturing. Designed to accelerate the availability of new medicines to patients, this digitally-enabled facility cut speed to patient by 50% and increased labour productivity in the laboratory by 67% through advanced automation, robotics and modular environments enabling scientists to spend more time on high-value-add tasks. The continuous platform reduces capital expenditure need for a new commercial plant by 80%, establishing a scalable foundation for next-generation biologics production.